BAMCO Inc
APLT

BAMCO Inc’s Applied Therapeutics APLT Stock Holding History

BAMCO Inc’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-237,800
Closed -$4.94M – 399
2021
Q2 		$4.94M Hold
237,800
– – 0.01% 325
2021
Q1 		$4.46M Buy
237,800
+110,800
+87% +$2.39M 0.01% 322
2020
Q4 		$2.79M Sell
127,000
-3,591
-3% -$74.8K 0.01% 311
2020
Q3 		$2.71M Sell
130,591
-122,900
-48% -$3.2M 0.01% 291
2020
Q2 		$9.16M Buy
253,491
+163,400
+181% +$6.84M 0.03% 230
2020
Q1 		$2.94M Buy
+90,091
New +$3.64M 0.01% 261

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

BAMCO Inc's APLT Position: Q3 2021 in Review

BAMCO Inc sold out of Applied Therapeutics (APLT) in Q3 2021, closing a stake of 237,800 shares — an estimated $4.94M sold.

BAMCO Inc first reported a position in APLT in Q1 2020 and held it in 6 quarters. The position peaked at $9.16M in Q2 2020. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2021.

  • BAMCO Inc reported no remaining Applied Therapeutics position as of Q3 2021 after selling out during the quarter.
  • BAMCO Inc sold 237,800 Applied Therapeutics shares in Q3 2021, an estimated $4.94M.
  • BAMCO Inc first reported a position in Applied Therapeutics in Q1 2020 and held it in 6 quarters.
  • BAMCO Inc's Applied Therapeutics position peaked at $9.16M in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2021.

Based on BAMCO Inc's 13F filing for Q3 2021, filed 12 Nov 2021.